Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This process includes extensive molecular simulations of the receptor in its native membrane environment, along with ensemble virtual screening that accounts for its conformational mobility. In the case of dimeric or oligomeric receptors, the entire functional complex is modelled, identifying potential binding pockets on and between the subunits to encompass all possible mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
P01589
UPID:
IL2RA_HUMAN
Alternative names:
TAC antigen; p55
Alternative UPACC:
P01589; Q5W007
Background:
Interleukin-2 receptor subunit alpha, also known as TAC antigen or p55, plays a pivotal role in immune regulation. It acts as a receptor for interleukin-2, controlling the activity of regulatory T cells (TREGs), which are essential for maintaining immune tolerance by suppressing autoreactive T-cells.
Therapeutic significance:
The protein is implicated in Type 1 diabetes mellitus 10, a disorder affecting glucose homeostasis, and Immunodeficiency 41, characterized by immune dysregulation. These associations highlight its potential as a target for therapeutic interventions aimed at modulating immune responses and treating autoimmune diseases.